mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.7 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0094 |
0.7 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.7 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |